文献速递头颈外科

甲状腺癌中央区淋巴清扫术后乳糜漏分析

[Analysis of chyle leakage after central lymph node dissection for thyroid carcinoma].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2019-01-01

该回顾性研究分析了985例甲状腺癌根治术加中央区淋巴清扫患者,乳糜漏发生率为1.2%(12/985)。乳糜漏患者术后第1天引流量和住院天数显著高于无乳糜漏者,所有乳糜漏均经无脂饮食和负压引流等保守治疗治愈,无需二次手术。

要点

  • 甲状腺癌中央区淋巴清扫术后乳糜漏发生率为1.2%。
  • 乳糜漏患者术后第1天引流量和住院天数显著增加。
  • 无脂饮食和负压引流可治愈乳糜漏,一般无需二次手术。

核心结论

  • 甲状腺癌中央区淋巴清扫术后乳糜漏是少见并发症,可通过饮食控制、加压包扎及负压引流等保守治疗治愈,一般无需二次手术。

研究设计与样本

  • 回顾性分析2017年1月至2018年6月上海交通大学医学院附属仁济医院头颈外科985例甲状腺癌根治术加中央区淋巴清扫患者,分为无乳糜漏组(A组,n=973)和乳糜漏组(B组,n=12),B组再分左侧清扫B1组(n=5)和右侧清扫B2组(n=7)。

主要发现

  • 乳糜漏发生率为1.2%(12/985)。
  • A组与B组在年龄、性别、原发灶大小、中央区淋巴结清扫个数和转移个数上差异均无统计学意义(P值均>0.05)。
  • A组术后第1天引流量为(51.7±26.7)ml,平均住院天数为(3.4±0.8)d,均显著低于B组的(131.3±56.0)ml和(10.4±2.6)d(t值分别为-5.442、-11.238,P值均<0.001)。
  • B1组与B2组在年龄、原发灶大小、中央区淋巴结清扫个数、转移个数、术后第1天引流量和平均住院天数上差异均无统计学意义(P值均>0.05)。
  • B组乳糜漏均经保守治疗成功,无一例二次手术。

临床怎么用

  • 甲状腺癌中央区淋巴清扫术后应警惕乳糜漏,出现乳糜漏可采用无脂饮食和负压引流等保守治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the clinical characteristics, treatment and prognosis of chyle leakage after central lymph node dissection for thyroid cancer. Methods: A retrospective analysis was made of 985 patients who underwent surgical for thyroid carcinoma plus central lymph node dissection from January 2017 to June 2018 in Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University. Patients were divided into those without (group A, n=973) and with (group B, n=12) chyle leakage. Patients with chyle leakage who underwent left central lymph node dissection were divided into group B1 (n=5) and right central lymph node dissection into group B2 (n=7). Patients with chyle leakage were treated with fat-free diet and negative pressure drainage. SPSS 20.0 software was used to analyze the general condition, surgical pathology, postoperative drainage, hospitalization days, treatment and prognosis of patients in B1 and B2 groups. Results: The incidence of chyle leakage after central lymph node dissection for thyroid cancer was 1.2% (12/985). There were no significant differences in age, sex, size of primary lesion, number of lymph node dissection in central area and number of lymph node metastasis in central area between group A and group B (all P>0.05). The drainage volume on the first day after operation [((51.7±26.7)) ml] and the average hospitalization days [(3.4±0.8) d] in group A were significantly lower than those in group B ([131.3±56.0)]ml, [10.4±2.6)]d). The differences were statistically significant (t value was -5.442, -11.238, respectively, both P<0.001). There were no significant differences in age, size of primary lesion, number of lymph node dissection, number of lymph node metastasis, drainage volume on the first day after operation and average hospitalization days between group B1 and group B2 (all P>0.05). All chyle leakages in group B stopped after conservative management without surgical intervention. Conclusion: The occurrence of chyle leakage after central lymph node dissection is a rare complication. It can be cured by conservative treatment such as diet control, pressure bandaging and negative pressure drainage, and generally does not require secondary surgery. 目的: 分析甲状腺癌中央区淋巴清扫术后乳糜漏的临床特点、治疗措施及预后。 方法: 回顾性分析自2017年1月至2018年6月于上海交通大学医学院附属仁济医院头颈外科接受甲状腺癌根治术+中央区淋巴清扫术的患者985例,将未发生乳糜漏的患者归为A组,973例,发生乳糜漏的患者归为B组,12例。将B组患者中行左侧中央区淋巴清扫的患者归为B1组(5例),行右侧中央区淋巴清扫的患者归为B2组(7例),发生乳糜漏患者予无脂饮食及负压引流治疗。以SPSS 20.0软件统计分析B1、B2两组患者的一般情况、手术病理、术后引流量、住院天数、治疗情况和预后。 结果: 甲状腺癌中央区淋巴清扫术后乳糜漏发生率1.2%(12/985)。A组患者与B组患者相比,年龄、性别、原发灶大小、中央区淋巴结清扫个数和中央区淋巴结转移个数差异均无统计学意义(P值均>0.05)A组患者术后第1天引流量[(51.7±26.7)ml]及平均住院天数[(3.4±0.8)d],均明显低于B组患者([(131.3±56.0)ml、(10.4±2.6)d],差异有统计学意义(t值分别为-5.442、-11.238,P值均<0.001)。B1组和B2组之间,患者年龄、原发灶大小、中央区淋巴结清扫个数、中央区淋巴结转移个数、术后第1天引流量和平均住院天数差异均无统计学意义(P值均>0.05)。B组患者乳糜漏均为保守治疗成功,无一例进行二次手术治疗。 结论: 甲状腺癌中央区淋巴清扫术后乳糜漏是一比较少见的术后并发症,可通过饮食控制、加压包扎及负压引流等保守治疗而治愈,一般无需二次手术治疗。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Feng JL, Zhou QY, Chen J, et al. [Analysis of chyle leakage after central lymph node dissection for thyroid carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31434373. doi:10.3760/cma.j.issn.1673-0860.2019.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。